Keyphrases
Acute Phase
10%
Acute Therapy
10%
Acute Treatment
10%
Clinical Trial Registry
10%
Continuation Therapy
10%
Continuation Treatment
10%
Cumulative Probability
10%
Daily Dose
10%
Depression Recurrence
10%
DSM-IV
10%
Fluoxetine
30%
Hamilton Depression Rating Scale (HAM-D)
10%
Log-rank Test
10%
Long-term Efficacy
10%
Long-term Safety
10%
Maintenance Interval
10%
Maintenance Phase
100%
Maintenance Studies
10%
Maintenance Treatment
10%
Major Depressive Disorder
10%
Multiple Phases
10%
Placebo
40%
Recurrence Probability
10%
Recurrence Rate
10%
Recurrent Episodes
100%
Treatment Duration
10%
Unipolar Depression
10%
Venlafaxine
10%
Venlafaxine Extended Release
100%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
9%
DSM-IV
9%
Fluoxetine
27%
Major Depression
18%
Placebo
36%
Recurrent Disease
36%
Venlafaxine
100%
Neuroscience
Fluoxetine
27%
Hamilton Rating Scale for Depression
9%
Major Depressive Disorder
9%
Placebo
36%
Venlafaxine
100%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
9%
DSM-IV
9%
Fluoxetine
27%
Venlafaxine
100%